Dr Kamaneh Montazeri, MD | |
55 Fruit St, Boston, MA 02114-2696 | |
(617) 724-4000 | |
Not Available |
Full Name | Dr Kamaneh Montazeri |
---|---|
Gender | Female |
Speciality | Hematology/oncology |
Experience | 15 Years |
Location | 55 Fruit St, Boston, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457766149 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 259920 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Massachusetts General Hospital | Boston, MA | Hospital |
Brigham And Women's Hospital | Boston, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
The General Hospital Corporation | 6507803806 | 1054 |
News Archive
Dynamic Response Group, Inc. announced today preliminary results for the Areopedic product. The results brought a 74% gross margin with an average order of over $450 dollars.
A group of leading entrepreneurs and innovators will be gathering at the Royal Society of Medicine on Saturday 16 April to take part in the Society's 12th Medical Innovations Summit. Providing a twice-yearly platform for the presentation and discussion of inspirational ideas and developments in the field of medicine and healthcare, the Summits encourage innovators at the very beginning of their careers, as well as established clinicians and academics.
A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine. This could be extremely useful in repeatedly and inexpensively screening high-risk groups for certain conditions, including those for which a genetic tendency is possible – such as prostate cancer or certain kinds of kidney cancer.
More than 3 million Americans have glaucoma, a serious eye condition causing vision loss. Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
› Verified 4 days ago
Entity Name | Massachusetts General Physicians Organization Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
Dynamic Response Group, Inc. announced today preliminary results for the Areopedic product. The results brought a 74% gross margin with an average order of over $450 dollars.
A group of leading entrepreneurs and innovators will be gathering at the Royal Society of Medicine on Saturday 16 April to take part in the Society's 12th Medical Innovations Summit. Providing a twice-yearly platform for the presentation and discussion of inspirational ideas and developments in the field of medicine and healthcare, the Summits encourage innovators at the very beginning of their careers, as well as established clinicians and academics.
A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine. This could be extremely useful in repeatedly and inexpensively screening high-risk groups for certain conditions, including those for which a genetic tendency is possible – such as prostate cancer or certain kinds of kidney cancer.
More than 3 million Americans have glaucoma, a serious eye condition causing vision loss. Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
› Verified 4 days ago
Entity Name | The General Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
Dynamic Response Group, Inc. announced today preliminary results for the Areopedic product. The results brought a 74% gross margin with an average order of over $450 dollars.
A group of leading entrepreneurs and innovators will be gathering at the Royal Society of Medicine on Saturday 16 April to take part in the Society's 12th Medical Innovations Summit. Providing a twice-yearly platform for the presentation and discussion of inspirational ideas and developments in the field of medicine and healthcare, the Summits encourage innovators at the very beginning of their careers, as well as established clinicians and academics.
A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine. This could be extremely useful in repeatedly and inexpensively screening high-risk groups for certain conditions, including those for which a genetic tendency is possible – such as prostate cancer or certain kinds of kidney cancer.
More than 3 million Americans have glaucoma, a serious eye condition causing vision loss. Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kamaneh Montazeri, MD 330 Mount Auburn St, Mount Auburn Hospital, Cambridge, MA 02138-5502 Ph: (617) 499-5571 | Dr Kamaneh Montazeri, MD 55 Fruit St, Boston, MA 02114-2696 Ph: (617) 724-4000 |
News Archive
Dynamic Response Group, Inc. announced today preliminary results for the Areopedic product. The results brought a 74% gross margin with an average order of over $450 dollars.
A group of leading entrepreneurs and innovators will be gathering at the Royal Society of Medicine on Saturday 16 April to take part in the Society's 12th Medical Innovations Summit. Providing a twice-yearly platform for the presentation and discussion of inspirational ideas and developments in the field of medicine and healthcare, the Summits encourage innovators at the very beginning of their careers, as well as established clinicians and academics.
A Stanford study published in the journal Nature Biomedical Engineering in April 2020 reports the development of a new kind of toilet that can pick up signs of an extensive range of diseases, from molecules in stool and urine. This could be extremely useful in repeatedly and inexpensively screening high-risk groups for certain conditions, including those for which a genetic tendency is possible – such as prostate cancer or certain kinds of kidney cancer.
More than 3 million Americans have glaucoma, a serious eye condition causing vision loss. Using human stem cell models, researchers at Indiana University School of Medicine found they could analyze deficits within cells damaged by glaucoma, with the potential to use this information to develop new strategies to slow the disease process.
Studies performed by a Sanford Research scientist using an innovative stem-cell model for a fatal developmental disorder is the focus of a recent study published in Nature Medicine. Kevin Francis, Ph.D. uncovered unique cellular defects associated with Smith-Lemli-Opitz syndrome (SLOS) by modeling this disease using induced pluripotent stem cells.
› Verified 4 days ago
Kaitlyn My-tu Lam, MBBS Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-724-7738 | |
Kui Toh Gerard Leong, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit Street, Massachusetts General Hospital, Boston, MA 02114 Phone: 617-726-8862 | |
Ruma Rajbhandari, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Boston, MA 02115 Phone: 617-525-6841 | |
Alaka Ray, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2066 | |
Meghan E Sise, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114 Phone: 617-726-2862 | |
Aaron Dickstein, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Box 233, Boston, MA 02111 Phone: 617-636-5883 Fax: 617-636-9292 | |
Dr. Felicia Elizabeth Patch, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 801 Massachusetts Ave, Crosstown 2, Boston, MA 02118 Phone: 617-414-4376 Fax: 617-414-4676 |